Platelets and von Willebrand factor in atherogenesis
- PMID: 28174163
- PMCID: PMC5356449
- DOI: 10.1182/blood-2016-07-692673
Platelets and von Willebrand factor in atherogenesis
Abstract
The role of platelet adhesion, activation, and aggregation in acute atherothrombotic events such as myocardial infarction and stroke is well established. There is increasing evidence that platelet-endothelial interactions also contribute to early atherosclerotic plaque initiation and growth. Through these interactions, platelet-derived factors can contribute to the proinflammatory and mitogenic status of resident mural cells. Among the many putative mechanisms for platelet-endothelial interactions, increased endothelial-associated von Willebrand factor, particularly in a multimerized form, which interacts with platelet glycoproteins and integrins, is a major factor and represents a therapeutic target in early atherogenesis.
Figures
Similar articles
-
Novel Approaches to Fine-Tune Therapeutic Targeting of Platelets in Atherosclerosis: A Critical Appraisal.Thromb Haemost. 2020 Nov;120(11):1492-1504. doi: 10.1055/s-0040-1714352. Epub 2020 Aug 9. Thromb Haemost. 2020. PMID: 32772352 Review.
-
Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis.Circ Cardiovasc Imaging. 2015 Jul;8(7):e002765. doi: 10.1161/CIRCIMAGING.114.002765. Circ Cardiovasc Imaging. 2015. PMID: 26156014 Free PMC article.
-
Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor.Pediatr Res. 1999 Feb;45(2):270-5. doi: 10.1203/00006450-199902000-00019. Pediatr Res. 1999. PMID: 10022601
-
The role of von Willebrand factor and fibrinogen in the initiation of platelet adhesion to thrombogenic surfaces.Thromb Haemost. 1995 Jul;74(1):460-3. Thromb Haemost. 1995. PMID: 8578507 Review.
-
Role of the von Willebrand factor in atherogenesis.Artery. 1979 Mar;5(3):262-72. Artery. 1979. PMID: 316693
Cited by
-
Broader Perspective on Atherosclerosis-Selected Risk Factors, Biomarkers, and Therapeutic Approach.Int J Mol Sci. 2024 May 10;25(10):5212. doi: 10.3390/ijms25105212. Int J Mol Sci. 2024. PMID: 38791250 Free PMC article. Review.
-
Removal of endothelial surface-associated von villebrand factor suppresses accelerate datherosclerosis after myocardial infarction.J Transl Med. 2024 May 1;22(1):412. doi: 10.1186/s12967-024-05231-6. J Transl Med. 2024. PMID: 38693516 Free PMC article.
-
Human Coronary Artery Endothelial Cell Response to Porphyromonas gingivalis W83 in a Collagen Three-Dimensional Culture Model.Microorganisms. 2024 Jan 24;12(2):248. doi: 10.3390/microorganisms12020248. Microorganisms. 2024. PMID: 38399652 Free PMC article.
-
Proteomics study and protein biomarkers of malignant ventricular arrhythmia in acute myocardial infarction patients.Clin Transl Med. 2023 Nov;13(11):e1435. doi: 10.1002/ctm2.1435. Clin Transl Med. 2023. PMID: 37962003 Free PMC article. No abstract available.
-
SGLT2 Inhibitors in Aging-Related Cardiovascular Disease: A Review of Potential Mechanisms.Am J Cardiovasc Drugs. 2023 Nov;23(6):641-662. doi: 10.1007/s40256-023-00602-8. Epub 2023 Aug 24. Am J Cardiovasc Drugs. 2023. PMID: 37620652 Review.
References
-
- Gryglewski RJ, Chłopicki S, Uracz W, Marcinkiewicz E. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation. Med Sci Monit. 2001;7(1):1-16. - PubMed
-
- Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(23 suppl 1):III27-III32. - PubMed
-
- Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med. 2011;364(18):1746-1760. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical